Specify a stock or a cryptocurrency in the search bar to get a summary
Drägerwerk AG & Co. KGaA (pref)
DRW3Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh. Address: Moislinger Allee 53-55, Lübeck, Germany, 23558
Analytics
WallStreet Target Price
53.47 EURP/E ratio
7.5284Dividend Yield
3.92 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DRW3
Dividend Analytics DRW3
Dividend growth over 5 years
-59 %Continuous growth
1 yearPayout Ratio 5 years average
3 %Dividend History DRW3
Stock Valuation DRW3
Financials DRW3
Results | 2019 | Dynamics |